PRMT1 in human neoplasm: cancer biology and potential therapeutic target
Open Access
- 8 February 2024
- journal article
- review article
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 22 (1) , 1-24
Abstract
Protein arginine methyltransferase 1 (PRMT1), the predominant type I protein arginine methyltransferase, plays a crucial role in normal biological functions by catalyzing the methylation of arginine side chains, specifically monomethylarginine (MMA) and asymmetric dimethylarginine (ADMA), within proteins. Recent investigations have unveiled an association between dysregulated PRMT1 expression and the initiation and progression of tumors, significantly impacting patient prognosis, attributed to PRMT1’s involvement in regulating various facets of tumor cell biology, including DNA damage repair, transcriptional and translational regulation, as well as signal transduction. In this review, we present an overview of recent advancements in PRMT1 research across different tumor types, with a specific focus on its contributions to tumor cell proliferation, metastasis, invasion, and drug resistance. Additionally, we expound on the dynamic functions of PRMT1 during distinct stages of cancer progression, elucidating its unique regulatory mechanisms within the same signaling pathway and distinguishing between its promotive and inhibitory effects. Importantly, we sought to provide a comprehensive summary and analysis of recent research progress on PRMT1 in tumors, contributing to a deeper understanding of its role in tumorigenesis, development, and potential treatment strategies.Keywords
This publication has 153 references indexed in Scilit:
- Arginine methylation at a glanceJournal of Cell Science, 2007
- Cetuximab for the Treatment of Colorectal CancerNew England Journal of Medicine, 2007
- Alternative Splicing Yields Protein Arginine Methyltransferase 1 Isoforms with Distinct Activity, Substrate Specificity, and Subcellular LocalizationJournal of Biological Chemistry, 2007
- Target-Based Approach to Inhibitors of Histone Arginine MethyltransferasesJournal of Medicinal Chemistry, 2007
- The GAR Motif of 53BP1 is Arginine Methylated by PRMT1 and is Necessary for 53BP1 DNA Binding ActivityCell Cycle, 2005
- Small Molecule Regulators of Protein Arginine MethyltransferasesJournal of Biological Chemistry, 2004
- Structure of the Predominant Protein Arginine Methyltransferase PRMT1 and Analysis of Its Binding to Substrate PeptidesStructure, 2003
- Arginine N-Methyltransferase 1 Is Required for Early Postimplantation Mouse Development, but Cells Deficient in the Enzyme Are ViableMolecular and Cellular Biology, 2000
- PRMT1 Is the Predominant Type I Protein Arginine Methyltransferase in Mammalian CellsJournal of Biological Chemistry, 2000
- The Mammalian Immediate-early TIS21 Protein and the Leukemia-associated BTG1 Protein Interact with a Protein-arginine -MethyltransferaseJournal of Biological Chemistry, 1996